ArticleFrontiers in immunology2022

Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis.

Takeshi Iwasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.